Analysis of the risk factors of contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma
MU De-wu1 CHEN Mao-shan2 FAN Li1 DU Song-li1 YANG Hong-wei2▲#br#
1.Graduate School,Zunyi Medical University,Guizhou Province,Zunyi 563006,China;
2.Department of Breast and Thyroid Surgery,Suining Central Hospital,Sichuan Province,Suining 629000,China
Abstract:Objective To explore the risk factors of contralateral central lymph nodes(Cont-CLNs)metastasis in unilateral papillary thyroid carcinoma(uPTC).Methods The clinical data were collected from the uPTC patients who had underwent total thyroidectomy and bilateral central lymphadenectomy in Suining City Central Hospital from January 2014 to August 2020,and were analyzed retrospectively.And the risk factors related to Cont-CLNs were analyzed.Results A total of 119 eligible patients were collected,the rate of Cont-CLNs metastasis was 26.89%(32/119).The univariate analysis showed that Cont-CLNs metastasis was related to the Ipsi-CLNs metastasis,gender,diseased glandular lobe,tumor size,the distance between the lower edge of tumor and the lower edge of thyroid and Hashimoto's thyroiditis(P<0.05).The result of Logistic regression model revealed that Ipsi-CLNs metastasis,the distance between the lower edge of tumor and the lower edge of thyroid≤10 mm and male were independent risk factors of Cont-CLNs metastasis(P<0.05).Conclusion Cont-CLNs dissection should be considered when unilateral thyroid papillary carcinoma is associated with high-risk features such as Ipsi-CLNs metastasis,the distance between the lower edge of tumor and the lower edge of thyroid≤10 mm and male.
牟德武; 陈茂山;樊莉; 杜松丽;杨宏伟. 单侧甲状腺乳头状癌对侧中央区淋巴结转移的相关危险因素分析[J]. 中国当代医药, 2021, 28(14): 95-98转102.
MU De-wu; CHEN Mao-shan; FAN Li;DU Song-li; YANG Hong-wei. Analysis of the risk factors of contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma. 中国当代医药, 2021, 28(14): 95-98转102.
Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[2]
Ryu YJ,Kang SJ,Cho JS,et al.Identifying risk factors of lateral lymph node recurrence in clinically node-negative papillary thyroid cancer[J].Medicine(Baltimore),2018,97(51):e13435.
Giordano D,Valcavi R,Thompson GB,et al.Complications of Central Neck Dissection in Patients with Papillary Thyroid Carcinoma:Results of a Study on 1087 Patients and Review of the Literature[J].Thyroid,2012,22(9):911-917.
Jeon MJ,Yoon JH,Han J M,et al.The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma[J].Eur J Endocrinol,2013,168(2):219-225.
[12]
Attard A,Paladino NC,Monte AIL,et al.Skip metastases to lateral cervical lymph nodes in differentiated thyroid cancer:a systematic review[J].BMC Surg,2019,18(S1):112.
[13]
Lei J,Zhong J,Jiang K,et al.Skip lateral lymph node metastasis leaping over the central neck compartment in papillary thyroid carcinoma[J].Oncotarget,2017,8(16):27 022-27 033.
Yu W,Xu G,Sun J,et al.Carbon nanoparticles guide contralateral central neck dissection in patients with papillary thyroid cancer[J].Oncol Lett,2018,16(1):447-452.
[18]
Wei T,Chen R,Zou X,et al.Predictive factors of contralateral paratracheal lymph node metastasis in unilateral papillary thyroid carcinoma[J].Eur J Surg Oncol,2015,41(6):746-750.
[19]
Kim SY,Seok-Mo Kim,Chang H,et al.Lateral neck metastases in the ipsilateral and contralateral compartments of papillary thyroid carcinoma located in one lobe[J].ANZ J Surg,2019,89(11):E498-E501.
[21]
Liu W,Cheng R,Su Y,et al.Risk factors of central lymph node metastasis of papillary thyroid carcinoma:A singlecenter retrospective analysis of 3273 cases[J].Medicine(Baltimore),2017,96(43):e8365.